Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Chronic viral hepatitis C. Part 1. General considerations].

V P Conte1

  • 1Departamento de Gastroenterologia da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP.

Arquivos De Gastroenterologia
|March 10, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Chronic hepatitis by C virus. Part 2. Treatment].

Arquivos de gastroenterologia·2001
Same author

[Hepatocellular carcinoma. Part 2. Treatment].

Arquivos de gastroenterologia·2001
Same author

[Hepatocellular carcinoma. Part 1. General considerations and diagnosis].

Arquivos de gastroenterologia·2000
Same author

[Oddi's sphincter dysfunction].

Revista do Hospital das Clinicas·1991
Same author

Normal neuronal features of the human gallbladder and structural changes in cholelithiasis patients.

Revista do Hospital das Clinicas·1989
Same author

[Non-surgical treatment of biliary lithiasis].

Revista do Hospital das Clinicas·1989

Hepatitis C virus (HCV) infection is primarily transmitted through blood and drug use. While screening has reduced post-transfusion cases, understanding HCV genotypes and their impact on disease severity is crucial for developing effective vaccines.

Area of Science:

  • Hepatology and Virology: Focus on Hepatitis C Virus (HCV) and novel DNA virus (TTV).
  • Immunology: Exploring immune responses to HCV envelope E2 protein and vaccine development.
  • Epidemiology: Analyzing HCV genotype distribution and transmission routes.

Context:

  • Hepatitis C virus (HCV) identified in 1989 as the main cause of non-A, non-B hepatitis.
  • High prevalence linked to blood transfusions and intravenous drug abuse.
  • Advancements in screening have reduced post-transfusion hepatitis incidence.

Purpose:

  • To review the natural history, epidemiology, and clinical significance of Hepatitis C virus infection.
  • To explore the association between HCV genotypes and disease severity.
  • To discuss potential vaccine development strategies and the role of novel viruses like TTV.

Summary:

Related Experiment Videos

  • HCV genotype distribution varies geographically, with subtypes 1a, 3a, and 1b being most prevalent.
  • Subtype 1b is associated with a more severe disease course, mitochondrial dysfunction, and impaired oxidative phosphorylation.
  • Intrahepatic HCV levels are not determined by host or viral factors, and negative serum RT-PCR does not rule out liver infection.

Impact:

  • Understanding genotype-specific disease progression aids in targeted treatment and management.
  • Research into immune modulation and novel vaccine strategies offers hope for controlling highly mutable HCV.
  • Further investigation is needed to clarify the pathogenic role of TTV and its association with disease.